OriGene Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search

Published online on December 23, 2004, 10.1073/pnas.0408592102
PNAS | January 4, 2005 | vol. 102 | no. 1 | 192-197


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erdal, H.
Right arrow Articles by Linder, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erdal, H.
Right arrow Articles by Linder, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

MEDICAL SCIENCES
Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis

Hamdiye Erdal *, Maria Berndtsson *, Juan Castro *, Ulf Brunk {dagger}, Maria C. Shoshan *, and Stig Linder *, {ddagger}

*Cancer Center Karolinska, Department of Oncology-Pathology, Karolinska Institute and Hospital, S-171 76 Stockholm, Sweden; and {dagger}Department of Pharmacology, Linköping University, S-581 83 Linköping, Sweden

Communicated by Leo Sachs, Weizmann Institute of Science, Rehovot, Israel, November 18, 2004 (received for review September 27, 2004)

The p53 protein activates cellular death programs through multiple pathways. Because the high frequency of p53 mutations in human tumors is believed to contribute to resistance to commonly used chemotherapeutic agents, it is important to identify drugs that induce p53-independent cell death and to define the mechanisms of action of such drugs. Here we screened a drug library (the National Cancer Institute mechanistic set; 879 compounds with diverse mechanisms of actions) and identified 175 compounds that induced caspase cleavage of cytokeratin-18 in cultured HCT116 colon cancer cells at <5 µM. Interestingly, whereas most compounds elicited a stronger apoptotic response in cells with functional p53, significant apoptosis was observed also in p53-null cells. A subset of 15 compounds showing weak or no dependence on p53 for induction of apoptosis was examined in detail. Of these compounds, 11 were capable of activating caspase-3 in enucleated cells. Seven such compounds with nonnuclear targets were found to induce lysosomal membrane permeabilization (LMP). Translocation of the lysosomal proteases cathepsin B and cathepsin D into the cytosol was observed after treatment with these drugs, and apoptosis was inhibited by pepstatin A, an inhibitor of cathepsin D. Apoptosis depended on Bax, suggesting that LMP induced a mitochondrial apoptotic pathway. We conclude that a large number of potential anticancer drugs induce p53-independent apoptosis and that LMP is a mediator of many such responses.

anticancer drugs | cathepsin D | M30 antibody

Author contributions: H.E., M.B., and J.C. performed research; H.E., M.B., M.C.S., and S.L. analyzed data; U.B., M.C.S., and S.L. designed research; and U.B., M.C.S., and S.L. wrote the paper.

Abbreviations: AO, acridine orange; CK, cytokeratin; LMP, lysosomal membrane permeabilization; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; NCI, National Cancer Institute.

{ddagger} To whom correspondence should be addressed. E-mail: stig.linder{at}cck.ki.se.

© 2005 by The National Academy of Sciences of the USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?


This article has been cited by other articles in HighWire Press-hosted journals:


Home page
 Molecular Cancer TherapeuticsHome page
D. Maksimovic-Ivanic, S. Mijatovic, L. Harhaji, D. Miljkovic, D. Dabideen, K. Fan Cheng, K. Mangano, G. Malaponte, Y. Al-Abed, M. Libra, et al.
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
Mol. Cancer Ther., March 1, 2008; 7(3): 510 - 520.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
R. Herrmann, W. Fayad, S. Schwarz, M. Berndtsson, and S. Linder
Screening for Compounds That Induce Apoptosis of Cancer Cells Grown as Multicellular Spheroids
J Biomol Screen, January 1, 2008; 13(1): 1 - 8.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
N. Li, Y. Zheng, W. Chen, C. Wang, X. Liu, W. He, H. Xu, and X. Cao
Adaptor Protein LAPF Recruits Phosphorylated p53 to Lysosomes and Triggers Lysosomal Destabilization in Apoptosis
Cancer Res., December 1, 2007; 67(23): 11176 - 11185.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Laforge, F. Petit, J. Estaquier, and A. Senik
Commitment to Apoptosis in CD4+ T Lymphocytes Productively Infected with Human Immunodeficiency Virus Type 1 Is Initiated by Lysosomal Membrane Permeabilization, Itself Induced by the Isolated Expression of the Viral Protein Nef
J. Virol., October 15, 2007; 81(20): 11426 - 11440.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. D. Nascimento, M. A. F. Hayashi, A. Kerkis, V. Oliveira, E. B. Oliveira, G. Radis-Baptista, H. B. Nader, T. Yamane, I. L. dos Santos Tersariol, and I. Kerkis
Crotamine Mediates Gene Delivery into Cells through the Binding to Heparan Sulfate Proteoglycans
J. Biol. Chem., July 20, 2007; 282(29): 21349 - 21360.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. S. Carew, S. T. Nawrocki, C. N. Kahue, H. Zhang, C. Yang, L. Chung, J. A. Houghton, P. Huang, F. J. Giles, and J. L. Cleveland
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
Blood, July 1, 2007; 110(1): 313 - 322.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Di Piazza, C. Mader, K. Geletneky, M. Herrero y Calle, E. Weber, J. Schlehofer, L. Deleu, and J. Rommelaere
Cytosolic Activation of Cathepsins Mediates Parvovirus H-1-Induced Killing of Cisplatin and TRAIL-Resistant Glioma Cells
J. Virol., April 15, 2007; 81(8): 4186 - 4198.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Fujisawa, N. Kambe, M. Saito, R. Nishikomori, H. Tanizaki, N. Kanazawa, S. Adachi, T. Heike, J. Sagara, T. Suda, et al.
Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells
Blood, April 1, 2007; 109(7): 2903 - 2911.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Groth-Pedersen, M. S. Ostenfeld, M. Hoyer-Hansen, J. Nylandsted, and M. Jaattela
Vincristine Induces Dramatic Lysosomal Changes and Sensitizes Cancer Cells to Lysosome-Destabilizing Siramesine
Cancer Res., March 1, 2007; 67(5): 2217 - 2225.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. Kitareewan, B. D. Roebuck, E. Demidenko, R. D. Sloboda, and E. Dmitrovsky
Lysosomes and Trivalent Arsenic Treatment in Acute Promyelocytic Leukemia
J Natl Cancer Inst, January 3, 2007; 99(1): 41 - 52.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. K. Radhakrishnan, U. G. Bhat, D. E. Hughes, I-C. Wang, R. H. Costa, and A. L. Gartel
Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1
Cancer Res., October 1, 2006; 66(19): 9731 - 9735.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Z. Duan, R. Foster, D. A. Bell, J. Mahoney, K. Wolak, A. Vaidya, C. Hampel, H. Lee, and M. V. Seiden
Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian Cancer
Clin. Cancer Res., September 1, 2006; 12(17): 5055 - 5063.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
S. Gullon, C. Olano, M. S. Abdelfattah, A. F. Brana, J. Rohr, C. Mendez, and J. A. Salas
Isolation, characterization, and heterologous expression of the biosynthesis gene cluster for the antitumor anthracycline steffimycin.
Appl. Envir. Microbiol., June 1, 2006; 72(6): 4172 - 4183.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. S. Ostenfeld, N. Fehrenbacher, M. Hoyer-Hansen, C. Thomsen, T. Farkas, and M. Jaattela
Effective Tumor Cell Death by {sigma}-2 Receptor Ligand Siramesine Involves Lysosomal Leakage and Oxidative Stress
Cancer Res., October 1, 2005; 65(19): 8975 - 8983.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Fehrenbacher and M. Jaattela
Lysosomes as Targets for Cancer Therapy
Cancer Res., April 15, 2005; 65(8): 2993 - 2995.
[Abstract] [Full Text] [PDF]